Acne Vulgaris
Showing NaN - NaN of 42
Acne Vulgaris Trial in United States (SB204 2%, SB204 4%, Vehicle Gel)
Completed
- Acne Vulgaris
- SB204 2%
- +2 more
-
Hot Springs, Arkansas
- +19 more
Jan 8, 2019
Acne Vulgaris Trial in United States (SB204 4%, Vehicle Gel)
Completed
- Acne Vulgaris
- SB204 4%
- Vehicle Gel
-
Anaheim, California
- +54 more
Nov 15, 2018
Acne Vulgaris Trial in Canada, United States (CD0271 0.3% / CD1579 2.5%, CD0271 0.1% / CD1579 2.5%, Topical Gel Vehicle)
Completed
- Acne Vulgaris
- CD0271 0.3% / CD1579 2.5%
- +2 more
-
Birmingham, Alabama
- +30 more
May 28, 2018
Acne Vulgaris Trial in Canada, United States (IDP-120 Gel, IDP 120 Component A Gel, IDP 120 Component B Gel)
Completed
- Acne Vulgaris
- IDP-120 Gel
- +3 more
-
Encino, California
- +23 more
Dec 14, 2017
Acne Vulgaris Trial in United States (BPX-01 1% Minocycline Topical Gel, BPX-01 2% Minocycline Topical Gel, BPX-01 Vehicle
Completed
- Acne Vulgaris
- BPX-01 1% Minocycline Topical Gel
- +2 more
-
Santa Monica, California
- +14 more
Apr 12, 2017
Acne Vulgaris Trial in United States (Omiganan (CLS001) Topical Gel, Vehicle Topical Gel)
Completed
- Acne Vulgaris
- Omiganan (CLS001) Topical Gel
- Vehicle Topical Gel
-
Mobile, Alabama
- +28 more
Mar 24, 2017
Acne Vulgaris Trial in Belize, United States (Dapsone 5.0% Gel (SEEGPharm), Placebo, Dapsone 5.0% Gel (Allergan))
Completed
- Acne Vulgaris
- Dapsone 5.0% Gel (SEEGPharm)
- +2 more
-
Encino, California
- +35 more
Dec 19, 2016
Acne Vulgaris Trial in New York (Chromogenix Regenlite Transform Treatment, Chromogenix Regenlite Transform Placebo)
Withdrawn
- Acne Vulgaris
- Chromogenix Regenlite Transform Treatment
- Chromogenix Regenlite Transform Placebo
-
New York, New YorkSadick Research Group
Dec 5, 2016
Acne Vulgaris Trial in United States (CLS001 Topical Gel, CLS001 Topical Gel Vehicle)
Completed
- Acne Vulgaris
- CLS001 Topical Gel
- CLS001 Topical Gel Vehicle
-
Encino, California
- +19 more
Sep 1, 2015
Acne Vulgaris Trial in United States (YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300), Placebo)
Completed
- Acne Vulgaris
- YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
- Placebo
-
Mobile, Alabama
- +21 more
Dec 29, 2014
Acne Vulgaris Trial in United States (ANT-1207, Vehicle)
Completed
- Acne Vulgaris
- ANT-1207
- Vehicle
-
Birmingham, Alabama
- +14 more
Jun 28, 2013
Acne Vulgaris Trial in New York (Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel
Unknown status
- Acne Vulgaris
- Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
-
New York, New YorkMt Sinai Hospital, Department of Dermatology
Oct 6, 2011
Acne Vulgaris Trial in New York (clindamycin phosphate 1.2%/tretinoin 0.025% gel alone, clindamycin phosphate 1.2%/tretinoin
Unknown status
- Acne Vulgaris
- clindamycin phosphate 1.2%/tretinoin 0.025% gel alone
- clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
-
New York, New YorkMt Sinai Hospital - Dept of Dermatology
Aug 22, 2011